Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Remimazolam for Sedation in ICU Patients Undergoing Mechanical Ventilation: a Single Center, Randomized, Controlled, Non-inferiority Trial

NCT04815265 is registered in ClinicalTrials.gov with Tianjin Nankai Hospital as lead sponsor.

NCT NCT04815265
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04815265 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Remimazolam for Sedation in ICU Patients Undergoing Mechanical Ventilation: a Single Center, Randomized, Controlled, Non-inferiority Trial
Lead sponsor
Tianjin Nankai Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
April 1, 2021
Completion date
June 30, 2024
Enrollment
488 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

sedation